1 |
Tryptophan
| 1件: Tryptophan Tryptophan | 2件: Propanoic acid Propanoic acid; Tryptophan; | - | - | 2件: 6 6, 75 |
2 |
Tyrosine
| 1件: Tyrosine Tyrosine | 4件: Alanine Alanine; L-Tyrosine; Propanoic acid; Tyrosine; | - | - | 5件: 6 6, 75, 86, 111, 298 |
3 |
Threonine
| 1件: Threonine Threonine | 1件: Threonine Threonine; | - | - | 3件: 86 86, 96, 97 |
4 |
Taurine
| 1件: Taurine Taurine | 1件: Taurine Taurine; | - | - | 2件: 13 13, 337 |
5 |
Thioctic acid amide
| 1件: Lipoic acid Lipoic acid | 3件: Alpha Lipoic Acid Alpha Lipoic Acid; ALPHA-LIPOIC ACID; Lipoic acid; | - | - | 5件: 2 2, 5, 13, 14, 20 |
6 |
Trypsin, crystallized
| - | 0件: | - | - | - |
7 |
Tobramycin
| 1件: Tobramycin Tobramycin | 9件: Bethkis Bethkis; TOBI; TOBI PODHALER; TOBRAMICINA; TOBRAMYCIN; Tobramycin inhalation solution; TOBRAMYCIN SULFATE; Tobramycine; Tobramycinum; | - | - | 1件: 299 299 |
8 |
Testosterone
| 1件: Testosterone Testosterone | 1件: Testosterone Testosterone; | 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 9件: 1 1, 2, 3, 13, 60, 76, 78, 113, 265 |
9 |
Thioctic acid
| 1件: Lipoic acid Lipoic acid | 3件: Alpha Lipoic Acid Alpha Lipoic Acid; Alpha-lipoic acid; Lipoic Acid; | - | - | 5件: 2 2, 5, 13, 14, 20 |
10 |
Thrombin
| 1件: Thrombin Thrombin | 1件: Thrombin Thrombin; | - | - | 2件: 86 86, 88 |
11 |
Tretinoin
| 1件: Tretinoin Tretinoin | 5件: ATRA ATRA; Retinoic acid; Tretinoin; TRETINOINA; VESANOID; | 3件: PML PML, RARA, RARB 💬 | 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 6件: 2 2, 62, 63, 75, 94, 231 |
12 |
Tacrolimus
| 1件: Tacrolimus Tacrolimus | 2件: Prograf Prograf; Tacrolimus; | 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
13 |
Trimethoprim
| 1件: Trimethoprim Trimethoprim | 2件: Bactrim Bactrim; Trimethoprim; | - | - | 8件: 36 36, 44, 49, 60, 61, 85, 298, 299 |
14 |
Testolactone
| - | 0件: | - | - | - |
15 |
Tolmetin sodium
| - | 0件: | - | - | - |
16 |
Tetracycline
| 1件: Tetracycline Tetracycline | 2件: Tetracyclin Tetracyclin; Tetracycline; | - | - | 5件: 13 13, 36, 46, 53, 97 |
17 |
Trolamine
| - | 0件: | - | - | - |
18 |
Temazepam
| - | 0件: | - | - | - |
19 |
Theophylline
| 1件: Theophylline Theophylline | 1件: Theophylline Theophylline; | 18件: ADORA1 ADORA1, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 | 23件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 236 236, 299 |
20 |
Thiabendazole
| - | 0件: | - | - | - |
21 |
Thioridazine
| - | 0件: | - | - | - |
22 |
Thiothixene
| - | 0件: | - | - | - |
23 |
Timolol
| 1件: Timolol Timolol | 2件: Timolol Timolol; TIMOLOL MALEATE; | 2件: ADRB1 ADRB1, ADRB2 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 157 157, 227 |
24 |
Tolazamide
| - | 0件: | - | - | - |
25 |
Tolbutamide
| - | 0件: | - | - | - |
26 |
Tolnaftate
| - | 0件: | - | - | - |
27 |
Torsemide
| - | 0件: | - | - | - |
28 |
Trandolapril
| - | 0件: | - | - | - |
29 |
Triacetin
| 1件: Triacetin Triacetin | 1件: Glyceryl triacetate Glyceryl triacetate; | - | - | 1件: 307 307 |
30 |
Triamcinolone
| 1件: Triamcinolone Triamcinolone | 4件: Kenalog Kenalog; Naltrexone; Triamcinolone; TRIAMCINOLONE ACETONIDE; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 10件: 35 35, 46, 56, 70, 90, 96, 107, 162, 226, 298 |
31 |
Triamterene
| - | 0件: | - | - | - |
32 |
Triazolam
| - | 0件: | - | - | - |
33 |
Triflupromazine
| - | 0件: | - | - | - |
34 |
Trifluridine
| - | 0件: | - | - | - |
35 |
Trimethadione
| - | 0件: | - | - | - |
36 |
Trimipramine
| - | 0件: | - | - | - |
37 |
Troglitazone
| - | 0件: | - | - | - |
38 |
Tromethamine
| 1件: Tromethamine Tromethamine | 4件: Tham Tham; Tris; Trometamol; Tromethamine; | - | - | 5件: 51 51, 96, 97, 226, 299 |
39 |
Tropicamide
| 1件: Tropicamide Tropicamide | 1件: Tropicamide Tropicamide; | 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 3件: 6 6, 13, 19 |
40 |
Terfenadine
| - | 0件: | - | - | - |
41 |
Topiramate
| 1件: Topiramate Topiramate | 2件: TOPAMAX TOPAMAX; Topiramate; | 36件: CA2 CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 53件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 6件: 6 6, 97, 140, 144, 156, 193 |
42 |
Tetracaine
| - | 0件: | - | - | - |
43 |
Thiotepa
| 1件: Thiotepa Thiotepa | 1件: Thiotepa Thiotepa; | - | - | 12件: 13 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284, 285 |
44 |
Timolol maleate
| 1件: Timolol Timolol | 2件: Timolol Timolol; TIMOLOL MALEATE; | 2件: ADRB1 ADRB1, ADRB2 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 157 157, 227 |
45 |
Terazosin hydrochloride
| 1件: Terazosin Terazosin | 1件: Terazosin Terazosin; | 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
46 |
Trimetaphan camsilate
| 1件: Trimethaphan Trimethaphan | 1件: Trimethaphan Trimethaphan; | 1件: CHRNA10 CHRNA10 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 17 17 |
47 |
Telmisartan
| 1件: Telmisartan Telmisartan | 1件: Telmisartan Telmisartan; | 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 66 66, 67 |
48 |
Tolterodine
| 1件: Tolterodine Tolterodine | 1件: Tolterodine Tolterodine; | 1件: CHRM3 CHRM3 💬 | 11件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 2件: 17 17, 53 |
49 |
Trichlormethiazide
| - | 0件: | - | - | - |
50 |
Tazobactam
| 1件: Tazobactam Tazobactam | 1件: TAZOBACTAM TAZOBACTAM; | - | - | 1件: 299 299 |
51 |
Terbutaline sulfate
| 1件: Terbutaline Terbutaline | 1件: Terbutaline Terbutaline; | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 118 118 |
52 |
Thiopental sodium
| - | 0件: | - | - | - |
53 |
Tridihexethyl chloride
| - | 0件: | - | - | - |
54 |
Thalidomide
| 1件: Thalidomide Thalidomide | 1件: THALIDOMIDE THALIDOMIDE; | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 20件: 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 |
55 |
Tizanidine hydrochloride
| 1件: Tizanidine Tizanidine | 1件: Tizanidine Tizanidine; | 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 13 13 |
56 |
Tolcapone
| 1件: Tolcapone Tolcapone | 3件: Tasmar Tasmar; Tolcapon; Tolcapone; | 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 3件: 6 6, 28, 127 |
57 |
Trihexyphenidyl hydrochloride
| 1件: Trihexyphenidyl Trihexyphenidyl | 1件: Trihexyphenidyl Trihexyphenidyl; | 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 2件: 5 5, 6 |
58 |
Thioridazine hydrochloride
| - | 0件: | - | - | - |
59 |
Trifluoperazine hydrochloride
| 1件: Trifluoperazine Trifluoperazine | 1件: Trifluoperazine Trifluoperazine; | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 283 283, 284 |
60 |
Triflupromazine hydrochloride
| - | 0件: | - | - | - |
61 |
Trazodone hydrochloride
| 1件: Trazodone Trazodone | 1件: Trazodone Trazodone; | 4件: HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 2 2 |
62 |
Tranylcypromine sulfate
| - | 0件: | - | - | - |
63 |
Thimerosal
| - | 0件: | - | - | - |
64 |
Terconazole
| - | 0件: | - | - | - |
65 |
Tioconazole
| - | 0件: | - | - | - |
66 |
Testosterone cypionate
| 1件: Testosterone Testosterone | 1件: Testosterone Testosterone; | 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 9件: 1 1, 2, 3, 13, 60, 76, 78, 113, 265 |
67 |
Testosterone enanthate
| 2件: Testosterone Testosterone, Testosterone enanthate | 3件: Testosterone Testosterone; Testosterone Enanthate; Xyosted; | 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 11件: 1 1, 2, 3, 13, 13, 60, 76, 78, 113, 113, 265 |
68 |
Testosterone propionate
| 2件: Testosterone Testosterone, Testosterone propionate | 2件: Testosterone Testosterone; Testosterone propionate; | 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 10件: 1 1, 2, 3, 13, 60, 76, 78, 113, 113, 265 |
69 |
Tamoxifen citrate
| 1件: Tamoxifen Tamoxifen | 2件: TAMOXIFEN TAMOXIFEN; TAMOXIFEN CITRATE; | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 4件: 2 2, 86, 113, 227 |
70 |
Toremifene citrate
| - | 0件: | - | - | - |
71 |
Triamcinolone acetonide
| 1件: Triamcinolone Triamcinolone | 4件: Kenalog Kenalog; Naltrexone; Triamcinolone; TRIAMCINOLONE ACETONIDE; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 10件: 35 35, 46, 56, 70, 90, 96, 107, 162, 226, 298 |
72 |
Triamcinolone diacetate
| 1件: Triamcinolone Triamcinolone | 4件: Kenalog Kenalog; Naltrexone; Triamcinolone; TRIAMCINOLONE ACETONIDE; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 10件: 35 35, 46, 56, 70, 90, 96, 107, 162, 226, 298 |
73 |
Triamcinolone hexacetonide
| 1件: Triamcinolone Triamcinolone | 4件: Kenalog Kenalog; Naltrexone; Triamcinolone; Triamcinolone Acetonide; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 10件: 35 35, 46, 56, 70, 90, 96, 107, 162, 226, 298 |
74 |
Tolazoline hydrochloride
| - | 0件: | - | - | - |
75 |
Tamsulosin hydrochloride
| - | 0件: | - | - | - |
76 |
Ticlopidine hydrochloride
| - | 0件: | - | - | - |
77 |
Tirofiban hydrochloride
| - | 0件: | - | - | - |
78 |
Tragacanth
| - | 0件: | - | - | - |
79 |
Trioxsalen
| - | 0件: | - | - | - |
80 |
Thymol
| 1件: Thymol Thymol | 1件: Thymol Thymol; | - | - | 1件: 13 13 |
81 |
Telithromycin
| - | 0件: | - | - | - |
82 |
Tigecycline
| 1件: Tigecycline Tigecycline | 1件: Tigecycline Tigecycline; | - | - | 1件: 93 93 |
83 |
Talc
| - | 0件: | - | - | - |
84 |
Tribenoside
| - | 0件: | - | - | - |
85 |
Trospium chloride
| - | 0件: | - | - | - |
86 |
Thiethylperazine maleate
| - | 0件: | - | - | - |
87 |
Tazarotene
| - | 0件: | - | - | - |
88 |
Tranexamic acid
| 1件: Tranexamic acid Tranexamic acid | 1件: Tranexamic Acid Tranexamic Acid; | 1件: PLG PLG 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬 | 6件: 46 46, 70, 215, 227, 288, 299 |
89 |
Tolterodine tartrate
| 1件: Tolterodine Tolterodine | 1件: Tolterodine Tolterodine; | 1件: CHRM3 CHRM3 💬 | 11件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 2件: 17 17, 53 |
90 |
Trilostane
| - | 0件: | - | - | - |
91 |
Tolfenamic acid
| 1件: Tolfenamic acid Tolfenamic acid | 1件: Tolfenamic Acid Tolfenamic Acid; | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 5 5 |
92 |
Tiemonium iodide
| - | 0件: | - | - | - |
93 |
Tolvaptan
| 1件: Tolvaptan Tolvaptan | 3件: Jinarc Jinarc; Samsca; TOLVAPTAN; | 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 3件: 67 67, 72, 225 |
94 |
Trapidil
| - | 0件: | - | - | - |
95 |
Tegafur
| 1件: Tegafur Tegafur | 0件: | 1件: TYMS TYMS 💬 | 4件: Antifolate resistance Antifolate resistance, Metabolic pathways, One carbon pool by folate, Pyrimidine metabolism 💬 | 1件: 46 46 |
96 |
Tofisopam
| - | 0件: | - | - | - |
97 |
Tesaglitazar
| - | 0件: | - | - | - |
98 |
Troxipide
| - | 0件: | - | - | - |
99 |
Troleandomycin
| - | 0件: | - | - | - |
100 |
Tiaprofenic acid
| - | 0件: | - | - | - |
101 |
Terguride
| 1件: Terguride Terguride | 1件: Terguride Terguride; | 2件: DRD2 DRD2, PRL 💬 | 12件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 51 51, 86 |
102 |
Tramadol hydrochloride
| 1件: Tramadol Tramadol | 2件: Tramadol Tramadol; Ultracet; | 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 5件: 46 46, 70, 78, 226, 271 |
103 |
Trepibutone
| - | 0件: | - | - | - |
104 |
Tolciclate
| - | 0件: | - | - | - |
105 |
Thiamphenicol
| - | 0件: | - | - | - |
106 |
Tamibarotene
| 1件: Tamibarotene Tamibarotene | 1件: Tamibarotene Tamibarotene; | 1件: RARA RARA 💬 | 5件: Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Pathways in cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 2件: 26 26, 96 |
107 |
Tinidazole
| - | 0件: | - | - | - |
108 |
Tiopronin
| - | 0件: | - | - | - |
109 |
Trifluoperazine maleate
| 1件: Trifluoperazine Trifluoperazine | 1件: Trifluoperazine Trifluoperazine; | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 283 283, 284 |
110 |
Tibolone
| - | 0件: | - | - | - |
111 |
Theophylline sodium acetate
| 1件: Theophylline Theophylline | 1件: Theophylline Theophylline; | 18件: ADORA1 ADORA1, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 | 23件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 236 236, 299 |
112 |
Tenoxicam
| - | 0件: | - | - | - |
113 |
Triprolidine hydrochloride
| - | 0件: | - | - | - |
114 |
Teprenone
| - | 0件: | - | - | - |
115 |
Tripamide
| - | 0件: | - | - | - |
116 |
Titanium dioxide
| - | 0件: | - | - | - |
117 |
Transfluthrin
| - | 0件: | - | - | - |
118 |
Tannic acid
| - | 0件: | - | - | - |
119 |
Travoprost
| - | 0件: | - | - | - |
120 |
Trimetoquinol hydrochloride
| - | 0件: | - | - | - |
121 |
Tenofovir disoproxil fumarate
| 1件: Tenofovir disoproxil Tenofovir disoproxil | 4件: Tenofovir Tenofovir; Tenofovir disoproxil; Tenofovir Disoproxil Fumarate; TRUVADA; | - | - | 2件: 93 93, 265 |
122 |
Tadalafil
| 1件: Tadalafil Tadalafil | 4件: Adcirca Adcirca; CIALIS; TADALAFIL; TADALAFILO; | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 7件: 6 6, 51, 75, 84, 86, 113, 210 |
123 |
Tranilast
| 1件: Tranilast Tranilast | 1件: Tranilast Tranilast; | - | - | 4件: 46 46, 84, 106, 113 |
124 |
Tacrine hydrochloride
| 1件: Tacrine Tacrine | 0件: | 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 3件: 46 46, 271, 299 |
125 |
Tocainide hydrochloride
| - | 0件: | - | - | - |
126 |
Tripelennamine hydrochloride
| - | 0件: | - | - | - |
127 |
Tiagabine hydrochloride
| - | 0件: | - | - | - |
128 |
Trovafloxacin mesylate
| - | 0件: | - | - | - |
129 |
Tropisetron
| - | 0件: | - | - | - |
130 |
Teicoplanin
| 1件: Teicoplanin Teicoplanin | 1件: Teicoplanin Teicoplanin; | - | - | 2件: 70 70, 299 |
131 |
Trichomycin
| - | 0件: | - | - | - |
132 |
Tulobuterol
| 1件: Tulobuterol Tulobuterol | 1件: Tulobuterol Tulobuterol; | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
133 |
Topotecan hydrochloride
| 1件: Topotecan Topotecan | 1件: Topotecan Topotecan; | 1件: TOP1 TOP1 💬 | - | 1件: 25 25 |
134 |
Tubocurarine chloride
| - | 0件: | - | - | - |
135 |
Terbinafine hydrochloride
| 1件: Terbinafine Terbinafine | 1件: Terbinafine Terbinafine; | - | - | 3件: 96 96, 97, 271 |
136 |
Trimeprazine tartrate
| - | 0件: | - | - | - |
137 |
Tiludronate disodium
| - | 0件: | - | - | - |
138 |
Tolrestat
| - | 0件: | - | - | - |
139 |
Tocopherol
| 1件: Tocopherol Tocopherol | 2件: Tocoferol Tocoferol; Tocopherol; | - | - | 6件: 13 13, 49, 90, 206, 257, 298 |
140 |
Thiethylperazine
| - | 0件: | - | - | - |
141 |
Tolmetin
| - | 0件: | - | - | - |
142 |
Terbinafine
| 1件: Terbinafine Terbinafine | 1件: Terbinafine Terbinafine; | - | - | 3件: 96 96, 97, 271 |
143 |
Ticrynafen
| - | 0件: | - | - | - |
144 |
Trimipramine maleate
| - | 0件: | - | - | - |
145 |
Temafloxacin hydrochloride
| - | 0件: | - | - | - |
146 |
Tylosin
| - | 0件: | - | - | - |
147 |
Tilmicosin
| - | 0件: | - | - | - |
148 |
Tobramycin sulfate
| 1件: Tobramycin Tobramycin | 9件: Bethkis Bethkis; TOBI; TOBI PODHALER; TOBRAMICINA; TOBRAMYCIN; Tobramycin inhalation solution; TOBRAMYCIN SULFATE; Tobramycine; Tobramycinum; | - | - | 1件: 299 299 |
149 |
Toloxatone
| - | 0件: | - | - | - |
150 |
Tianeptine
| - | 0件: | - | - | - |
151 |
Tocilizumab
| 1件: Tocilizumab Tocilizumab | 3件: Actemra Actemra; ROACTEMRA; Tocilizumab; | 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 21件: 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 |
152 |
Thiethylperazine malate
| - | 0件: | - | - | - |
153 |
Trifluperidol
| - | 0件: | - | - | - |
154 |
Talampanel
| 1件: Talampanel Talampanel | 1件: Talampanel Talampanel; | 4件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4 💬 | 16件: Amphetamine addiction Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 2件: 2 2, 6 |
155 |
Teniposide
| - | 0件: | - | - | - |
156 |
Talniflumate
| 1件: Talniflumate Talniflumate | 1件: Talniflumate Talniflumate; | - | - | 1件: 299 299 |
157 |
Tarazepide
| - | 0件: | - | - | - |
158 |
Tibezonium iodide
| - | 0件: | - | - | - |
159 |
Tegaserod maleate
| - | 0件: | - | - | - |
160 |
Trimethobenzamide hydrochloride
| 1件: Trimethobenzamide Trimethobenzamide | 3件: Tigan Tigan; Trimethobenzamide; Trimethobenzamide Hydrochloride; | - | - | 1件: 6 6 |
161 |
Teceleukin
| - | 0件: | - | - | - |
162 |
Trastuzumab
| - | 0件: | - | - | - |
163 |
Tyloxapol
| - | 0件: | - | - | - |
164 |
Thiamine disulfide
| - | 0件: | - | - | - |
165 |
Trafermin
| - | 0件: | - | - | - |
166 |
Tipifarnib
| 1件: Tipifarnib Tipifarnib | 1件: Tipifarnib Tipifarnib; | 2件: FNTA FNTA, FNTB 💬 | 1件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis 💬 | 1件: 34 34 |
167 |
Tanomastat
| - | 0件: | - | - | - |
168 |
Telinavir
| - | 0件: | - | - | - |
169 |
Tipranavir disodium
| 1件: Tipranavir Tipranavir | 1件: Tipranavir Tipranavir; | - | - | 1件: 265 265 |
170 |
Tacedinaline
| - | 0件: | - | - | - |
171 |
Talabostat
| - | 0件: | - | - | - |
172 |
Talactoferrin alfa
| - | 0件: | - | - | - |
173 |
Tanaproget
| - | 0件: | - | - | - |
174 |
Tandutinib
| - | 0件: | - | - | - |
175 |
Tapentadol
| - | 0件: | - | - | - |
176 |
Tariquidar
| - | 0件: | - | - | - |
177 |
Tasosartan
| - | 0件: | - | - | - |
178 |
Tecadenoson
| - | 0件: | - | - | - |
179 |
Tecastemizole
| - | 0件: | - | - | - |
180 |
Technetium Tc 99m sulfur colloid
| - | 0件: | - | - | - |
181 |
Teclozan
| - | 0件: | - | - | - |
182 |
Teduglutide
| 1件: Teduglutide Teduglutide | 1件: Teduglutide Teduglutide; | 1件: GLP2R GLP2R 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 |
183 |
Tefibazumab
| 1件: Tefibazumab Tefibazumab | 1件: Tefibazumab Tefibazumab; | - | - | 1件: 299 299 |
184 |
Tegaserod
| - | 0件: | - | - | - |
185 |
Telbermin
| - | 0件: | - | - | - |
186 |
Temefos
| - | 0件: | - | - | - |
187 |
Temocillin
| - | 0件: | - | - | - |
188 |
Temoporfin
| - | 0件: | - | - | - |
189 |
Temozolomide
| 1件: Temozolomide Temozolomide | 1件: Temozolomide Temozolomide; | - | - | 1件: 34 34 |
190 |
Temsirolimus
| 1件: Temsirolimus Temsirolimus | 1件: Temsirolimus Temsirolimus; | 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 4件: 13 13, 34, 89, 331 |
191 |
Tenecteplase
| - | 0件: | - | - | - |
192 |
Tenidap
| - | 0件: | - | - | - |
193 |
Tenofovir
| 1件: Tenofovir Tenofovir | 1件: Tenofovir Tenofovir; | - | - | 6件: 2 2, 13, 25, 93, 265, 325 |
194 |
Tepoxalin
| - | 0件: | - | - | - |
195 |
Terbogrel
| - | 0件: | - | - | - |
196 |
Teriparatide
| 1件: Teriparatide Teriparatide | 4件: Forsteo Forsteo; Forteo; PTH 1-34; Teriparatide; | 1件: PTH1R PTH1R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 7件: 46 46, 65, 68, 70, 71, 235, 274 |
197 |
Terpin hydrate
| - | 0件: | - | - | - |
198 |
Testosterone ketolaurate
| 1件: Testosterone Testosterone | 1件: Testosterone Testosterone; | 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 9件: 1 1, 2, 3, 13, 60, 76, 78, 113, 265 |
199 |
Testosterone undecanoate
| 2件: Testosterone Testosterone, Testosterone undecanoate | 2件: Testosterone Testosterone; Testosterone undecanoate; | 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 11件: 1 1, 2, 3, 13, 13, 60, 60, 76, 78, 113, 265 |
200 |
Tetrofosmin
| - | 0件: | - | - | - |
201 |
Tetroxoprim
| - | 0件: | - | - | - |
202 |
Tetracycline metaphosphate
| - | 0件: | - | - | - |
203 |
Tezacitabine
| - | 0件: | - | - | - |
204 |
Theophylline
| 1件: Theophylline Theophylline | 1件: Theophylline Theophylline; | 18件: ADORA1 ADORA1, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 | 23件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 236 236, 299 |
205 |
Theophylline sodium glycinate
| 1件: Theophylline Theophylline | 1件: Theophylline Theophylline; | 18件: ADORA1 ADORA1, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 | 23件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 236 236, 299 |
206 |
Thiamylal
| - | 0件: | - | - | - |
207 |
Thioguanine
| 1件: Tioguanine Tioguanine | 0件: | 1件: HPRT1 HPRT1 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 2件: 13 13, 37 |
208 |
Thiostrepton
| - | 0件: | - | - | - |
209 |
Thiram
| - | 0件: | - | - | - |
210 |
Thymalfasin
| 1件: Thymalfasin Thymalfasin | 1件: THYMALFASIN THYMALFASIN; | - | - | 2件: 65 65, 299 |
211 |
Thymopentin
| - | 0件: | - | - | - |
212 |
Thyroglobulin
| - | 0件: | - | - | - |
213 |
Thyrotropin alfa
| - | 0件: | - | - | - |
214 |
Tiamulin
| - | 0件: | - | - | - |
215 |
Tiazofurin
| - | 0件: | - | - | - |
216 |
Ticlatone
| - | 0件: | - | - | - |
217 |
Tifacogin
| - | 0件: | - | - | - |
218 |
Tioxidazole
| - | 0件: | - | - | - |
219 |
Tirapazamine
| - | 0件: | - | - | - |
220 |
Tocainide
| - | 0件: | - | - | - |
221 |
Tocladesine
| - | 0件: | - | - | - |
222 |
Tocophersolan
| 1件: Tocofersolan Tocofersolan | 1件: VEDROP VEDROP; | - | - | 1件: 299 299 |
223 |
Tolbutamide sodium, sterile
| - | 0件: | - | - | - |
224 |
Tolu balsam
| - | 0件: | - | - | - |
225 |
Toralizumab
| 1件: Toralizumab Toralizumab | 1件: Anti-CD40L Anti-CD40L; | 1件: CD40LG CD40LG 💬 | 14件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis 💬 | 1件: 63 63 |
226 |
Torapsel
| - | 0件: | - | - | - |
227 |
Torcetrapib
| - | 0件: | - | - | - |
228 |
Trabectedin
| 1件: Trabectedin Trabectedin | 2件: TRABECTEDINA TRABECTEDINA; Yondelis; | - | - | 1件: 159 159 |
229 |
Tramiprosate
| - | 0件: | - | - | - |
230 |
Trenbolone acetate
| - | 0件: | - | - | - |
231 |
Treprostinil
| 1件: Treprostinil Treprostinil | 4件: Remodulin Remodulin; Treprostinil; Treprostinilo; Tyvaso; | 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 6件: 51 51, 84, 85, 86, 88, 210 |
232 |
Trestolone acetate
| - | 0件: | - | - | - |
233 |
Triamcinolone acetonide sodium phosphate
| 1件: Triamcinolone Triamcinolone | 4件: Kenalog Kenalog; Naltrexone; Triamcinolone; Triamcinolone Acetonide; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 10件: 35 35, 46, 56, 70, 90, 96, 107, 162, 226, 298 |
234 |
Triciribine phosphate
| - | 0件: | - | - | - |
235 |
Triclocarban
| - | 0件: | - | - | - |
236 |
Triclofenol piperazine
| 1件: Piperazine Piperazine | 1件: Piperazine Piperazine; | - | - | 2件: 58 58, 272 |
237 |
Triclosan
| - | 0件: | - | - | - |
238 |
Trimegestone
| - | 0件: | - | - | - |
239 |
Trimethoprim sulfate
| 1件: Trimethoprim Trimethoprim | 2件: Bactrim Bactrim; Trimethoprim; | - | - | 8件: 36 36, 44, 49, 60, 61, 85, 298, 299 |
240 |
Trimetrexate
| - | 0件: | - | - | - |
241 |
Trimetrexate glucuronate
| - | 0件: | - | - | - |
242 |
Tripelennamine citrate
| - | 0件: | - | - | - |
243 |
Triptorelin
| 1件: Triptorelin Triptorelin | 2件: GnRH GnRH; Triptorelin; | 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 2件: 49 49, 76 |
244 |
Trodusquemine
| - | 0件: | - | - | - |
245 |
Troxacitabine
| - | 0件: | - | - | - |
246 |
Typhoid vaccine
| - | 0件: | - | - | - |
247 |
Tyrothricin
| - | 0件: | - | - | - |
248 |
Tafluprost
| 1件: Tafluprost Tafluprost | 1件: TAFLUPROST TAFLUPROST; | 1件: PTGFR PTGFR 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬 | 1件: 299 299 |
249 |
Thrombomodulin alfa
| 1件: Thrombomodulin Alfa Thrombomodulin Alfa | 1件: Thrombomodulin Alfa Thrombomodulin Alfa; | 1件: F2 F2 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | 1件: 85 85 |
250 |
Tanespimycin
| - | 0件: | - | - | - |
251 |
Tedisamil
| - | 0件: | - | - | - |
252 |
Tesamorelin
| 1件: Tesamorelin Tesamorelin | 2件: GHRH GHRH; Tesamorelin; | 1件: GHRHR GHRHR 💬 | 2件: Growth hormone synthesis, secretion and action Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬 | 2件: 78 78, 265 |
253 |
Tezampanel
| - | 0件: | - | - | - |
254 |
Tremelimumab
| 1件: Tremelimumab Tremelimumab | 1件: Ticilimumab Ticilimumab; | 1件: CTLA4 CTLA4 💬 | 4件: Autoimmune thyroid disease Autoimmune thyroid disease, Cell adhesion molecules, Rheumatoid arthritis, T cell receptor signaling pathway 💬 | 1件: 96 96 |
255 |
Tipelukast
| 1件: Tipelukast Tipelukast | 1件: Tipelukast Tipelukast; | 1件: CYSLTR1 CYSLTR1 💬 | 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 85 85 |
256 |
Terlipressin
| 1件: Terlipressin Terlipressin | 1件: TERLIPRESSIN TERLIPRESSIN; | 3件: AVPR1A AVPR1A, AVPR1B, AVPR2 💬 | 5件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬 | 1件: 299 299 |
257 |
Telbivudine
| 1件: Telbivudine Telbivudine | 0件: | - | - | 1件: 65 65 |
258 |
Talbutal
| - | 0件: | - | - | - |
259 |
Tiropramide
| - | 0件: | - | - | - |
260 |
Tioclomarol
| - | 0件: | - | - | - |
261 |
Triflusal
| - | 0件: | - | - | - |
262 |
Taurolidine
| - | 0件: | - | - | - |
263 |
Theodrenaline
| - | 0件: | - | - | - |
264 |
Tiracizine
| - | 0件: | - | - | - |
265 |
Tolonidine
| - | 0件: | - | - | - |
266 |
Troxerutin
| - | 0件: | - | - | - |
267 |
Tertatolol
| - | 0件: | - | - | - |
268 |
Talinolol
| - | 0件: | - | - | - |
269 |
Tiadenol
| - | 0件: | - | - | - |
270 |
Thenalidine
| - | 0件: | - | - | - |
271 |
Tolpropamine
| - | 0件: | - | - | - |
272 |
Tromantadine
| - | 0件: | - | - | - |
273 |
Tioxolone
| - | 0件: | - | - | - |
274 |
Tiratricol
| 1件: Tiratricol Tiratricol | 1件: Tiratricol Tiratricol; | 2件: THRA THRA, THRB 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | 2件: 78 78, 139 |
275 |
Tiocarlide
| - | 0件: | - | - | - |
276 |
Terizidone
| - | 0件: | - | - | - |
277 |
Trofosfamide
| - | 0件: | - | - | - |
278 |
Treosulfan
| 1件: Treosulfan Treosulfan | 2件: OVASTAT OVASTAT; TREOSULFAN; | - | - | 6件: 13 13, 19, 62, 65, 283, 286 |
279 |
Triaziquone
| - | 0件: | - | - | - |
280 |
Thiocolchicoside
| - | 0件: | - | - | - |
281 |
Tetrazepam
| - | 0件: | - | - | - |
282 |
Tisopurine
| - | 0件: | - | - | - |
283 |
Tropatepine
| - | 0件: | - | - | - |
284 |
Tilbroquinol
| - | 0件: | - | - | - |
285 |
Tenonitrozole
| - | 0件: | - | - | - |
286 |
Triclabendazole
| - | 0件: | - | - | - |
287 |
Tetramethrin
| - | 0件: | - | - | - |
288 |
Tuaminoheptane
| - | 0件: | - | - | - |
289 |
Tymazoline
| - | 0件: | - | - | - |
290 |
Thebacon
| - | 0件: | - | - | - |
291 |
Talastine
| - | 0件: | - | - | - |
292 |
Tritoqualine
| - | 0件: | - | - | - |
293 |
Trimazosin
| - | 0件: | - | - | - |
294 |
Turofexorate isopropyl
| - | 0件: | - | - | - |
295 |
Trolamine salicylate
| - | 0件: | - | - | - |
296 |
Tacalcitol
| - | 0件: | - | - | - |
297 |
Tacrine
| 1件: Tacrine Tacrine | 0件: | 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 3件: 46 46, 271, 299 |
298 |
Tacrolimus
| 1件: Tacrolimus Tacrolimus | 2件: Prograf Prograf; Tacrolimus; | 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
299 |
Talampicillin
| - | 0件: | - | - | - |
300 |
Tamoxifen
| 1件: Tamoxifen Tamoxifen | 2件: Tamoxifen Tamoxifen; TAMOXIFEN CITRATE; | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 4件: 2 2, 86, 113, 227 |
301 |
Tamsulosin
| - | 0件: | - | - | - |
302 |
Tandospirone
| - | 0件: | - | - | - |
303 |
Tasonermin
| - | 0件: | - | - | - |
304 |
Temocapril
| - | 0件: | - | - | - |
305 |
Terazosin
| 1件: Terazosin Terazosin | 1件: Terazosin Terazosin; | 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
306 |
Terbutaline
| 1件: Terbutaline Terbutaline | 1件: Terbutaline Terbutaline; | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 118 118 |
307 |
Testosterone decanoate
| 1件: Testosterone decanoate Testosterone decanoate | 1件: Testosterone decanoate Testosterone decanoate; | 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 113 113 |
308 |
Testosterone phenylpropionate
| 1件: Testosterone phenylpropionate Testosterone phenylpropionate | 1件: Testosterone phenylpropionate Testosterone phenylpropionate; | 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 113 113 |
309 |
Tetrabenazine
| 1件: Tetrabenazine Tetrabenazine | 2件: Tetrabenazine Tetrabenazine; Xenazine; | 1件: SLC18A2 SLC18A2 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 8 8 |
310 |
Tetramisole
| - | 0件: | - | - | - |
311 |
Tetryzoline
| - | 0件: | - | - | - |
312 |
Thiamine
| 1件: Thiamine Thiamine | 2件: THIAMINE THIAMINE; Vitamin B1; | - | - | 5件: 8 8, 13, 93, 145, 265 |
313 |
Thioacetazone
| - | 0件: | - | - | - |
314 |
Thioproperazine
| - | 0件: | - | - | - |
315 |
Thiosalicylic acid
| - | 0件: | - | - | - |
316 |
Thonzylamine
| - | 0件: | - | - | - |
317 |
Tiagabine
| - | 0件: | - | - | - |
318 |
Tiapride
| 1件: Tiapride Tiapride | 0件: | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 8 8 |
319 |
Ticarcillin
| 1件: Ticarcillin Ticarcillin | 1件: Ticarcillin Ticarcillin; | - | - | 1件: 299 299 |
320 |
Ticlopidine
| - | 0件: | - | - | - |
321 |
Tiletamine
| - | 0件: | - | - | - |
322 |
Tilidine
| - | 0件: | - | - | - |
323 |
Tiludronic acid
| - | 0件: | - | - | - |
324 |
Timolol
| 1件: Timolol Timolol | 2件: Timolol Timolol; TIMOLOL MALEATE; | 2件: ADRB1 ADRB1, ADRB2 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 157 157, 227 |
325 |
Timonacic
| - | 0件: | - | - | - |
326 |
Tinoridine
| - | 0件: | - | - | - |
327 |
Tioguanine
| 1件: Tioguanine Tioguanine | 0件: | 1件: HPRT1 HPRT1 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 2件: 13 13, 37 |
328 |
Tipepidine
| - | 0件: | - | - | - |
329 |
Tipranavir
| 1件: Tipranavir Tipranavir | 1件: Tipranavir Tipranavir; | - | - | 1件: 265 265 |
330 |
Tirilazad
| - | 0件: | - | - | - |
331 |
Tirofiban
| - | 0件: | - | - | - |
332 |
Tixocortol
| - | 0件: | - | - | - |
333 |
Tizanidine
| 1件: Tizanidine Tizanidine | 1件: Tizanidine Tizanidine; | 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 13 13 |
334 |
Tolazoline
| - | 0件: | - | - | - |
335 |
Teneligliptin
| - | 0件: | - | - | - |
336 |
Tolperisone
| 1件: Tolperisone Tolperisone | 1件: Tolperisone Tolperisone; | - | - | 1件: 13 13 |
337 |
Topotecan
| 1件: Topotecan Topotecan | 1件: Topotecan Topotecan; | 1件: TOP1 TOP1 💬 | - | 1件: 25 25 |
338 |
Toremifene
| - | 0件: | - | - | - |
339 |
Tositumomab
| - | 0件: | - | - | - |
340 |
Tramadol
| 1件: Tramadol Tramadol | 2件: Tramadol Tramadol; Ultracet; | 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 5件: 46 46, 70, 78, 226, 271 |
341 |
Tramazoline
| - | 0件: | - | - | - |
342 |
Tranylcypromine
| - | 0件: | - | - | - |
343 |
Trazodone
| 1件: Trazodone Trazodone | 1件: Trazodone Trazodone; | 4件: HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 2 2 |
344 |
Trenbolone
| - | 0件: | - | - | - |
345 |
Tretoquinol
| - | 0件: | - | - | - |
346 |
Trichloroacetic acid
| - | 0件: | - | - | - |
347 |
Triclofos
| - | 0件: | - | - | - |
348 |
Trifluoperazine
| 1件: Trifluoperazine Trifluoperazine | 1件: Trifluoperazine Trifluoperazine; | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 283 283, 284 |
349 |
Trihexyphenidyl
| 1件: Trihexyphenidyl Trihexyphenidyl | 1件: Trihexyphenidyl Trihexyphenidyl; | 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 2件: 5 5, 6 |
350 |
Trimebutine
| 1件: Trimebutine Trimebutine | 1件: Trimebutine Trimebutine; | 2件: OPRK1 OPRK1, OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 51 51 |
351 |
Trimetazidine
| 1件: Trimetazidine Trimetazidine | 1件: Trimetazidine Trimetazidine; | - | - | 3件: 2 2, 58, 86 |
352 |
Trimethobenzamide
| 1件: Trimethobenzamide Trimethobenzamide | 3件: Tigan Tigan; Trimethobenzamide; Trimethobenzamide Hydrochloride; | - | - | 1件: 6 6 |
353 |
Tripelennamine
| - | 0件: | - | - | - |
354 |
Triphosadenine
| - | 0件: | - | - | - |
355 |
Triprolidine
| - | 0件: | - | - | - |
356 |
Troclosene
| - | 0件: | - | - | - |
357 |
Trovafloxacin
| - | 0件: | - | - | - |
358 |
Tagatose
| - | 0件: | - | - | - |
359 |
Taranabant
| - | 0件: | - | - | - |
360 |
Tarenflurbil
| 1件: Tarenflurbil Tarenflurbil | 2件: FLURBIPROFEN FLURBIPROFEN; Tarenflurbil; | 4件: APH1A APH1A, NCSTN, PSEN1, PSENEN 💬 | 6件: Alzheimer disease Alzheimer disease, Human papillomavirus infection, Neurotrophin signaling pathway, Notch signaling pathway, Pathways of neurodegeneration - multiple diseases, Wnt signaling pathway 💬 | 1件: 13 13 |
361 |
Telaprevir
| - | 0件: | - | - | - |
362 |
Teplizumab
| - | 0件: | - | - | - |
363 |
Terameprocol
| - | 0件: | - | - | - |
364 |
Thrombin alfa
| - | 0件: | - | - | - |
365 |
Ticagrelor
| 1件: Ticagrelor Ticagrelor | 1件: Ticagrelor Ticagrelor; | 1件: P2RY12 P2RY12 💬 | 1件: Platelet activation Platelet activation 💬 | 3件: 36 36, 46, 85 |
366 |
Tofimilast
| - | 0件: | - | - | - |
367 |
Tucotuzumab celmoleukin
| - | 0件: | - | - | - |
368 |
Thiopropazate
| - | 0件: | - | - | - |
369 |
Talarozole
| - | 0件: | - | - | - |
370 |
Talmapimod
| - | 0件: | - | - | - |
371 |
Tanezumab
| 1件: Tanezumab Tanezumab | 1件: Tanezumab Tanezumab; | 1件: NGF NGF 💬 | 9件: Apoptosis Apoptosis, Calcium signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 2件: 226 226, 298 |
372 |
Tasimelteon
| 1件: Tasimelteon Tasimelteon | 1件: Tasimelteon Tasimelteon; | 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 202 202 |
373 |
Tecovirimat
| - | 0件: | - | - | - |
374 |
Telcagepant
| - | 0件: | - | - | - |
375 |
Tafamidis
| 1件: Tafamidis Tafamidis | 2件: Tafamidis Tafamidis; Vyndaqel; | 1件: TTR TTR 💬 | 1件: Thyroid hormone synthesis Thyroid hormone synthesis 💬 | 1件: 28 28 |
376 |
Taliglucerase alfa
| 1件: Taliglucerase alfa Taliglucerase alfa | 3件: Elelyso Elelyso; PrGCD; TALIGLUCERASE ALFA; | 1件: GBA GBA 💬 | 4件: Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | 1件: 19 19 |
377 |
Tecarfarin
| - | 0件: | - | - | - |
378 |
Teprotumumab
| 1件: Teprotumumab Teprotumumab | 1件: TEPEZZA TEPEZZA; | 1件: IGF1R IGF1R 💬 | 29件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, HIF-1 signaling pathway, Hepatocellular carcinoma, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | 1件: 51 51 |
379 |
Tipapkinogene sovacivec
| - | 0件: | - | - | - |
380 |
Tivozanib
| - | 0件: | - | - | - |
381 |
Tonapofylline
| - | 0件: | - | - | - |
382 |
Tedizolid
| 1件: Tedizolid Tedizolid | 1件: Tedizolid Tedizolid; | - | - | 1件: 299 299 |
383 |
Tedizolid phosphate
| - | 0件: | - | - | - |
384 |
Taspoglutide
| - | 0件: | - | - | - |
385 |
Topiroxostat
| - | 0件: | - | - | - |
386 |
Talimogene laherparepvec
| - | 0件: | - | - | - |
387 |
Taprenepag
| - | 0件: | - | - | - |
388 |
Tofacitinib
| 1件: Tofacitinib Tofacitinib | 4件: Tasocitinib Tasocitinib; Tofacitinib; XELJANZ; Xeljanz XR; | 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬 | 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 15件: 11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271 |
389 |
Tegobuvir
| - | 0件: | - | - | - |
390 |
Telapristone acetate
| - | 0件: | - | - | - |
391 |
Telotristat
| 1件: Telotristat Telotristat | 1件: Telotristat Telotristat; | 2件: TPH1 TPH1, TPH2 💬 | 4件: Folate biosynthesis Folate biosynthesis, Metabolic pathways, Serotonergic synapse, Tryptophan metabolism 💬 | 1件: 97 97 |
392 |
Telotristat ethyl
| - | 0件: | - | - | - |
393 |
Temanogrel
| - | 0件: | - | - | - |
394 |
Tofogliflozin
| - | 0件: | - | - | - |
395 |
Tralokinumab
| 1件: Tralokinumab Tralokinumab | 1件: Tralokinumab Tralokinumab; | 1件: IL13 IL13 💬 | 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | 2件: 85 85, 97 |
396 |
Trastuzumab emtansine
| - | 0件: | - | - | - |
397 |
Tosedostat
| - | 0件: | - | - | - |
398 |
Tylvalosin
| - | 0件: | - | - | - |
399 |
Tabalumab
| 1件: Tabalumab Tabalumab | 1件: Tabalumab Tabalumab; | 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 2件: 46 46, 49 |
400 |
Tanzisertib
| - | 0件: | - | - | - |
401 |
Tavaborole
| - | 0件: | - | - | - |
402 |
Tedatioxetine
| - | 0件: | - | - | - |
403 |
Teriflunomide
| 1件: Teriflunomide Teriflunomide | 2件: AUBAGIO AUBAGIO; TERIFLUNOMIDE; | 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 3件: 13 13, 25, 26 |
404 |
Tivantinib
| - | 0件: | - | - | - |
405 |
Tozadenant
| 1件: Tozadenant Tozadenant | 1件: TOZADENANT TOZADENANT; | 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
406 |
Trametinib
| 1件: Trametinib Trametinib | 2件: Mekinist Mekinist; Trametinib; | 2件: MAP2K1 MAP2K1, MAP2K2 💬 | 89件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 4件: 2 2, 34, 279, 280 |
407 |
Trebananib
| - | 0件: | - | - | - |
408 |
Trelagliptin
| - | 0件: | - | - | - |
409 |
Trabedersen
| - | 0件: | - | - | - |
410 |
Turoctocog alfa
| - | 0件: | - | - | - |
411 |
Tirasemtiv
| 1件: Tirasemtiv Tirasemtiv | 1件: Tirasemtiv Tirasemtiv; | - | - | 1件: 2 2 |
412 |
Tildrakizumab
| 1件: Tildrakizumab Tildrakizumab | 2件: Ilumetri Ilumetri; Tildrakizumab; | 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 162 162, 271 |
413 |
Trenonacog alfa
| - | 0件: | - | - | - |
414 |
Tovetumab
| - | 0件: | - | - | - |
415 |
Tenofovir alafenamide
| 1件: Tenofovir alafenamide Tenofovir alafenamide | 1件: Tenofovir alafenamide Tenofovir alafenamide; | - | - | 2件: 2 2, 13 |
416 |
Tafenoquine
| - | 0件: | - | - | - |
417 |
Tildipirosin
| - | 0件: | - | - | - |
418 |
Trabodenoson
| - | 0件: | - | - | - |
419 |
Taladegib
| 1件: Taladegib Taladegib | 1件: Taladegib Taladegib; | 1件: SMO SMO 💬 | 5件: Axon guidance Axon guidance, Basal cell carcinoma, Hedgehog signaling pathway, Pathways in cancer, Proteoglycans in cancer 💬 | 1件: 85 85 |
420 |
Talazoparib
| - | 0件: | - | - | - |
421 |
Temsavir
| - | 0件: | - | - | - |
422 |
Toreforant
| - | 0件: | - | - | - |
423 |
Turoctocog alfa pegol
| - | 0件: | - | - | - |
424 |
Tucidinostat
| - | 0件: | - | - | - |
425 |
Tezacaftor
| 1件: Tezacaftor Tezacaftor | 5件: Kaftrio Kaftrio; Symdeko; Symkevi; TEZACAFTOR; Trikafta; | 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
426 |
Tibulizumab
| 1件: Tibulizumab Tibulizumab | 1件: Tibulizumab Tibulizumab; | 2件: IL17A IL17A, TNFSF13B 💬 | 8件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 53 53 |
427 |
Trilaciclib
| - | 0件: | - | - | - |
428 |
Tucatinib
| - | 0件: | - | - | - |
429 |
Tinostamustine
| - | 0件: | - | - | - |
430 |
Trifarotene
| - | 0件: | - | - | - |
431 |
Tavilermide
| - | 0件: | - | - | - |
432 |
Trevogrumab
| - | 0件: | - | - | - |
433 |
Taldefgrobep alfa
| - | 0件: | - | - | - |
434 |
Tozuleristide
| - | 0件: | - | - | - |
435 |
Telisotuzumab
| - | 0件: | - | - | - |
436 |
Telisotuzumab vedotin
| - | 0件: | - | - | - |
437 |
Tagraxofusp
| - | 0件: | - | - | - |
438 |
Tirzepatide
| - | 0件: | - | - | - |
439 |
Tapinarof
| - | 0件: | - | - | - |
440 |
Trastuzumab duocarmazine
| - | 0件: | - | - | - |
441 |
Tisagenlecleucel-T
| - | 0件: | - | - | - |
442 |
Troriluzole
| - | 0件: | - | - | - |
443 |
Tavapadon
| 1件: Tavapadon Tavapadon | 2件: PF-06649751 PF-06649751; TAVAPADON; | 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
444 |
Tazemetostat
| - | 0件: | - | - | - |
445 |
Tomivosertib
| - | 0件: | - | - | - |
446 |
Triheptanoin
| 1件: Triheptanoin Triheptanoin | 1件: Triheptanoin Triheptanoin; | - | - | 10件: 2 2, 8, 65, 149, 156, 248, 256, 257, 317, 324 |
447 |
Tiragolumab
| - | 0件: | - | - | - |
448 |
Tislelizumab
| - | 0件: | - | - | - |
449 |
Tomaralimab
| - | 0件: | - | - | - |
450 |
Tilsotolimod
| - | 0件: | - | - | - |
451 |
Trastuzumab deruxtecan
| - | 0件: | - | - | - |
452 |
Tropifexor
| 1件: Tropifexor Tropifexor | 1件: Tropifexor Tropifexor; | 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 1件: 93 93 |
453 |
Tafasitamab
| - | 0件: | - | - | - |
454 |
Tenapanor
| - | 0件: | - | - | - |
455 |
Tirbanibulin
| - | 0件: | - | - | - |
456 |
Tepotinib
| - | 0件: | - | - | - |
457 |
Taniborbactam
| - | 0件: | - | - | - |
458 |
Tradipitant
| - | 0件: | - | - | - |
459 |
Telaglenastat
| - | 0件: | - | - | - |
460 |
Tezepelumab
| - | 0件: | - | - | - |
461 |
Tesevatinib
| 1件: Tesevatinib Tesevatinib | 1件: Tesevatinib Tesevatinib; | 5件: EGFR EGFR, EPHB4, ERBB2, FLT4, KDR 💬 | 53件: Adherens junction Adherens junction, Axon guidance, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Platinum drug resistance, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction, VEGF signaling pathway 💬 | 1件: 67 67 |
462 |
Taselisib
| - | 0件: | - | - | - |
463 |
Tarextumab
| - | 0件: | - | - | - |
464 |
Tofersen
| 1件: Tofersen Tofersen | 1件: Tofersen Tofersen; | 1件: SOD1 SOD1 💬 | 8件: Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis, Chemical carcinogenesis - reactive oxygen species, Huntington disease, Longevity regulating pathway - multiple species, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Peroxisome, Prion disease 💬 | 1件: 2 2 |
465 |
Tisotumab vedotin
| - | 0件: | - | - | - |
466 |
Taurursodiol
| 1件: Tauroursodeoxycholic acid Tauroursodeoxycholic acid | 2件: Tauroursodeoxycholic acid Tauroursodeoxycholic acid; TUDCA; | - | - | 4件: 2 2, 13, 93, 299 |
467 |
Tozinameran
| 1件: Pfizer-BioNTech COVID-19 Vaccine Pfizer-BioNTech COVID-19 Vaccine | 2件: Comirnaty Comirnaty; Tozinameran; | - | - | 5件: 13 13, 46, 51, 53, 299 |
468 |
Tixagevimab
| - | 0件: | - | - | - |
469 |
Thyme
| - | 0件: | - | - | - |
470 |
Thyme oil
| - | 0件: | - | - | - |
471 |
Teclistamab
| - | 0件: | - | - | - |
472 |
Tesnatilimab
| - | 0件: | - | - | - |
473 |
Talquetamab
| - | 0件: | - | - | - |
474 |
Toripalimab
| - | 0件: | - | - | - |
475 |
Tegoprazan
| - | 0件: | - | - | - |